Leritrelvir (RAY1216) is a potent, orally bioavailable SARS-CoV-2 main protease (Mpro) inhibitor. It functions by blocking the cleavage of viral polyproteins, thereby suppressing viral replication. This small molecule is a valuable research tool for in vitro antiviral assays and in vivo studies exploring therapeutic interventions against COVID-19.
Molekulargewicht:
639.71
Reinheit:
97.42% (May vary between batches)
CAS Nummer:
[2923310-64-7]
Formel:
C31H44F3N5O6
Target-Kategorie:
SARS-CoV
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten